抗生素口服治疗小儿肺炎可行性评价.docVIP

抗生素口服治疗小儿肺炎可行性评价[摘要] 目的:探讨抗生素口服途径治疗小儿肺炎的可行性、优越性。方法:在观察期间临床诊断为细菌性小儿肺炎的病例(非危重的,年龄6个月～5岁为主),随机分为抗生素口服观察组与抗生素静脉对照组,对病例的病情转归、不良反应、治疗过程患儿依从性等资料进行综合评价。结果:口服抗生素治疗小儿非严重肺炎与静脉使用抗生素的疗效差异无统计学意义,而小儿对治疗的依从性组间差异有统计学意义,口服途径有优势。结论:抗生素口服方法治疗非严重小儿肺炎是有效的,作为常规首选治疗非严重小儿肺炎的可行性、优越性更切合现行的医疗服务模式。 [关键词] 抗生素;肺炎;口服;小儿 [中图分类号] R725.6[文献标识码]C [文章编号]1673-7210(2010)06(a)-082-02 The feasibility evaluation for oral antibiotic treatment of pediatric in children FANG Licai (Maternal and Child Health Hospital in Chaozhou City, Guangdong Province, Chaozhou 521000, China) [Abstract] Objective: To investigate the feasibility and advantages of oral antibiotic treatment of pediatric pneumonia. Methods: During the observation of clinical cases were diagnosed as bacterial pneumonia in children (non-critical,6 months to 5 years of age), they were divided into oral antibiotics observation group and intravenous antibiotics control group randomly, the condition, adverse reaction, compliance of the sick children in treatment process of patients were comprehensively evaluated. Results: For non-severe pediatric pneumonia, the difference between oral antibiotics and intravenous antibiotic treatment was not statistically significant, there were statistically significant in compliance of the sick children of two groups, oral antibiotic had advantages. Conclusion: For non-severe pediatric pneumonia, oral antibiotics cure is effective, as a regular first choice for treatment of non-severe pneumonia in children, its possibility and superiority is accord with the current medical model. [Key words] Antibiotics; Pediatric; Oral; Children 目前在发展中国家中肺炎是5岁以下儿童的首要的致死病因,而应用抗生素是对可疑细菌感染患儿的常用疗法。小儿肺炎首选的治疗途径并没有具体的标准化,静脉输液的常规治疗模式对大部分小儿肺炎存在过度医疗的可能性,随着社会的发展和人文模式的转变,患儿家长对医疗服务模式提出不同层次的要求,常规静脉输液的传统模式面临人性化的考验,有必要重新分析传统模式的合理性并寻求既有效而又更人性化的医疗模式。 1 资料与方法 1.1 一般资料 选择2008年9月～2009年9月到我科就诊的肺炎患儿,年龄6个月～5岁,共240例。常规血细胞分析和胸部X线片检查诊断为小儿肺炎,考虑为细菌性感染,且为非严重病例。将所有患儿随机分为口服观察组与静脉对照组各120例,口服组年龄(2.2±1.3)岁;静脉组年龄(1.9±1.1)岁,两组比较,差异无统计学意义(